Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Cash from Financing Activities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Cash from Financing Activities for 3 consecutive years, with $149.2 million as the latest value for Q1 2026.

  • Quarterly Cash from Financing Activities rose 125463.03% to $149.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $362.0 million through Jan 2026, up 183.25% year-over-year, with the annual reading at $330.3 million for FY2025, 324.91% up from the prior year.
  • Cash from Financing Activities for Q1 2026 was $149.2 million at Kestra Medical Technologies, up from -$27000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $214.7 million in Q2 2025, with the low at -$1.9 million in Q3 2025.
  • Average Cash from Financing Activities over 3 years is $61.2 million, with a median of $6.1 million recorded in 2024.
  • The sharpest move saw Cash from Financing Activities tumbled 101.61% in 2025, then surged 125463.03% in 2026.
  • Over 3 years, Cash from Financing Activities stood at -$575000.0 in 2024, then skyrocketed by 95.3% to -$27000.0 in 2025, then soared by 552625.93% to $149.2 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $149.2 million, -$27000.0, and -$1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.